AIMS/HYPOTHESIS: Low phosphate and high calcium concentrations have been linked to altered glucose tolerance and reduced insulin sensitivity in non-diabetic individuals. The aim of this study was to examine the relationships of calcium and phosphate levels and the calcium-phosphate product with the development of type 2 diabetes. METHODS: Participants were 863 African-Americans, Hispanics and non-Hispanic whites in the Insulin Resistance Atherosclerosis Study who were free of diabetes at baseline. The mean follow-up period was 5.2 years. The insulin sensitivity index (SI) and acute insulin response (AIR) were directly measured using the frequently sampled IVGTT. RESULTS: Calcium concentration (OR per 1 SD unit increase, 1.26 [95% CI 1.04, 1.53]) and calcium-phosphate product (OR 1.29 [95% CI 1.04, 1.59]) were associated with incident diabetes after adjustment for demographic variables, family history of diabetes, and 2 h glucose. The relationship between phosphate concentration and progression to diabetes was close to statistical significance (OR 1.21 [95% CI 0.98, 1.49]). Calcium concentration (OR 1.37 [95% CI 1.09, 1.72]) and calcium-phosphate product (OR 1.39 [95% CI 1.09, 1.77]) remained associated with incident diabetes after additional adjustment for BMI, plasma glucose, SI, AIR, C-reactive protein, estimated GFR, diuretic drugs and total calcium intake. CONCLUSIONS/ INTERPRETATION: Elevated serum calcium and calcium-phosphate product are associated with increased risk of developing type 2 diabetes independently of measured glucose, insulin secretion and insulin resistance. Future studies need to analyse the role of calcium-phosphate homeostasis in the pathophysiology of diabetes.
AIMS/HYPOTHESIS: Low phosphate and high calcium concentrations have been linked to altered glucose tolerance and reduced insulin sensitivity in non-diabetic individuals. The aim of this study was to examine the relationships of calcium and phosphate levels and the calcium-phosphate product with the development of type 2 diabetes. METHODS:Participants were 863 African-Americans, Hispanics and non-Hispanic whites in the Insulin Resistance Atherosclerosis Study who were free of diabetes at baseline. The mean follow-up period was 5.2 years. The insulin sensitivity index (SI) and acute insulin response (AIR) were directly measured using the frequently sampled IVGTT. RESULTS:Calcium concentration (OR per 1 SD unit increase, 1.26 [95% CI 1.04, 1.53]) and calcium-phosphate product (OR 1.29 [95% CI 1.04, 1.59]) were associated with incident diabetes after adjustment for demographic variables, family history of diabetes, and 2 h glucose. The relationship between phosphate concentration and progression to diabetes was close to statistical significance (OR 1.21 [95% CI 0.98, 1.49]). Calcium concentration (OR 1.37 [95% CI 1.09, 1.72]) and calcium-phosphate product (OR 1.39 [95% CI 1.09, 1.77]) remained associated with incident diabetes after additional adjustment for BMI, plasma glucose, SI, AIR, C-reactive protein, estimated GFR, diuretic drugs and total calcium intake. CONCLUSIONS/ INTERPRETATION: Elevated serum calcium and calcium-phosphate product are associated with increased risk of developing type 2 diabetes independently of measured glucose, insulin secretion and insulin resistance. Future studies need to analyse the role of calcium-phosphate homeostasis in the pathophysiology of diabetes.
Authors: L E Wagenknecht; E J Mayer; M Rewers; S Haffner; J Selby; G M Borok; L Henkin; G Howard; P J Savage; M F Saad Journal: Ann Epidemiol Date: 1995-11 Impact factor: 3.797
Authors: Ravi Dhingra; Lisa M Sullivan; Caroline S Fox; Thomas J Wang; Ralph B D'Agostino; J Michael Gaziano; Ramachandran S Vasan Journal: Arch Intern Med Date: 2007-05-14
Authors: So Young Bu; Mi Ja Choi; Da Seul Choi; You-Mi Jung; In-Sil Jang; Narae Yang; Kirang Kim; Clara Yongjoo Park Journal: Nutr Res Pract Date: 2022-02-14 Impact factor: 1.992
Authors: C W Sing; V K F Cheng; D K C Ho; A W C Kung; B M Y Cheung; I C K Wong; K C B Tan; J Salas-Salvadó; N Becerra-Tomas; C L Cheung Journal: Osteoporos Int Date: 2015-12-11 Impact factor: 4.507
Authors: Mary R Rooney; James S Pankow; Shalamar D Sibley; Elizabeth Selvin; Jared P Reis; Erin D Michos; Pamela L Lutsey Journal: Am J Clin Nutr Date: 2016-08-10 Impact factor: 7.045
Authors: Jong Ha Baek; Sang Man Jin; Ji Cheol Bae; Jae Hwan Jee; Tae Yang Yu; Soo Kyoung Kim; Kyu Yeon Hur; Moon Kyu Lee; Jae Hyeon Kim Journal: Diabetes Metab J Date: 2016-12-26 Impact factor: 5.376
Authors: Hyun Sun Cho; Sung Won Lee; Juyoung Shin; Sung Dae Moon; Je Ho Han; Bong Yun Cha; Eun Sook Kim Journal: Medicine (Baltimore) Date: 2016-06 Impact factor: 1.889